Cellular-Enabled Glucometers and Maternal Glucose Control: A Quality Improvement Initiative
- PMID: 31216873
- PMCID: PMC7189156
- DOI: 10.1177/1932296819856360
Cellular-Enabled Glucometers and Maternal Glucose Control: A Quality Improvement Initiative
Abstract
Background: Management of diabetes in pregnancy is burdensome due to self-glucose monitoring, recording, and reporting demands. Cellular-enabled glucometers provide real-time transmission of glucose values independent of internet access and cell phone data plans. We describe a quality improvement (QI) intervention that introduced cellular-enabled glucometers for use during pregnancies complicated by diabetes.
Methods: Our aim was to improve maternal glucose control in a cohort of insulin-requiring pregnant women enrolled in a telemedicine diabetes program. During initial establishment of a QI program, women were offered cellular-enabled glucometers but could elect to keep their standard meter. The primary outcome evaluated was glycosylated hemoglobin A1c (HbA1c) at delivery.
Results: Baseline characteristics including initial HbA1c were similar between women using a standard glucometer (n = 45) and those using a cellular-enabled glucometer (n = 72). Women who used a cellular-enabled glucometer had a lower HbA1c at delivery compared to those using a standard glucometer (5.8% vs 6.3%, P = .03). This improvement was particularly notable for women with poor glucose control (defined as HbA1c >6.5%) at initial obstetric visit. Women with poor glucose control who used a cellular-enabled glucose monitor had significantly lower HbA1c at delivery (6.0% vs 6.8%, P = .03) and greater change from initial visit compared to those using a standard glucometer (-2.6% vs -1.4%, P = .02). No statistically significant differences were detected in tracked neonatal outcomes.
Conclusion: For pregnancies complicated by insulin-requiring diabetes, use of cellular-enabled glucometers as part of a perinatal diabetes program improves glucose control at delivery with timely transmission of accurate values throughout gestation.
Keywords: cellular-enabled glucometer; diabetes; glucometer; pregnancy; quality; telemedicine.
Conflict of interest statement
Figures
References
-
- American Diabetes Association. Management of diabetes in pregnancy: standards of medical care in diabetes—2019. Diabetes Care. 2019;42:S165-S72. - PubMed
-
- Gestational Diabetes Mellitus. ACOG Practice Bulletin No 190. Washington, DC: American College of Obstetricians and Gynecologists; 2018.
-
- Pregestational Diabetes Mellitus. ACOG Practice Bulletin No 201. Washington, DC: American College of Obstetricians and Gynecologists; 2018.
-
- Youngwanichsetha S, Phumdoung S. Lived experience of blood glucose self-monitoring among pregnant women with gestational diabetes mellitus: a phenomenological research. J Clin Nurs. 2017;26:2915-2921. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical